Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Bladder Cancer

fluorodeoxyglucose f18 has been researched along with Bladder Cancer in 163 studies

Research

Studies (163)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (4.29)	18.2507
2000's	27 (16.56)	29.6817
2010's	94 (57.67)	24.3611
2020's	35 (21.47)	2.80

Authors

Authors	Studies
Albersen, M; Berghen, C; De Maeseneer, D; De Man, K; De Meerleer, G; De Visschere, P; Decaestecker, K; Dirix, P; Fonteyne, V; Ost, P; Poppe, L; Rottey, S; Van Praet, C; Verbeke, S; Verghote, F; Villeirs, G	1
Kumar, S; Parmar, KM; Singh, P; Thummala, Y	1
Boormans, JL; Hinsenveld, FJ; Noordman, BJ; Oprea-Lager, DE; van Beek, SC; van der Pas, SL; van Leenders, GJLH; Vis, AN; Voortman, J	1
Bouchelouche, K	1
Bertolaso, P; Bladou, F; Brouste, V; Cabart, M; Cazeau, AL; de Clermont-Gallerande, H; Gross-Goupil, M; Lefort, F	1
Ali, F; McLeod, A; Schierz, JH	1
Dong, A; Zhao, B; Zuo, C	1
Dasgupta, P; Ghose, A; Hayes, JDB; Kandala, A; Omorphos, NP; Sharma, A; Vasdev, N	1
Baykal Koca, S; Beyhan, E; Çermik, TF; Ergül, N; Yücetaş, U	1
Akan, S; Ediz, C; Terzi, NK; Yilmaz, O	1
Dupin, C; Fitoussi, O; Galland, S; Gordien, P; Henriques, B; Kuratle, T; Poulain, JE; Ramos-Pascual, S; Riviere, J; Roche, JB; Saffarini, M; Vincent, M; Wallerand, H	1
Bot, F; Grootemaat, M; Roshani, H; Sampimon, D; Tjiam, I	1
Boellaard, TN; de Reijke, TM; Greidanus, J; Mertens, LS; Oosterbaan, L; van Gennep, EJ; van Ginkel, N; van Rhijn, BWG; Vis, AN; Wondergem, M	1
Kim, SJ; Ko, WS	1
Hassan, A; Mufty, S; Rana, MF	1
Kaji, T; Okabe, K; Takagi, Y; Takahashi, A; Takayanagi, A; Yorozuya, W	1
Altintas Taslicay, C; Cam, I; Civriz, AH; Demir, H; Kara, O	1
Aben, KKH; Kiemeney, LALM; Meijer, RP; Mertens, LS; Richters, A; Schoots, I; van Ginkel, N; van Rhijn, BWG; Vis, AN; Witjes, JA; Wondergem, M	1
Deng, Y; Wang, H; Xie, H; Zhang, W	1
Siegel, C	1
Altun, E; Basch, EM; Bjurlin, MA; Chen, RC; David, GU; Deal, AM; Eulitt, PJ; Godley, PA; Kim, WY; Lee, JK; Lin, W; Milowsky, MI; Nielsen, ME; Pruthi, RS; Ramirez, J; Rathmell, WK; Rose, TL; Sheikh, A; Smith, AB; Wallen, EM; Whang, YE; Wong, TZ; Woods, ME	1
Du, G; Fu, Z; Liu, L; Xue, M	1
Ahmad, W; Gill, SM; Hassan, A	1
Bhardwaj, H; Curley, M	1
Hagiwara, K; Hayashida, M; Nagamoto, S; Ogawa, K; Okaneya, T; Sakaguchi, K; Sawa, N; Urakami, S; Yano, A	1
Donswijk, ML; Einerhand, SMH; Hendricksen, K; Mertens, LS; van der Poel, HG; van Gennep, EJ; van Rhijn, BWG	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Alessi, A; Bandini, M; Bianchi, M; Briganti, A; Capitanio, U; Capozza, A; Colecchia, M; Farè, E; Fossati, N; Gallina, A; Gandaglia, G; Giannatempo, P; Marandino, L; Montorsi, F; Necchi, A; Padovano, B; Pederzoli, F; Raggi, D; Salonia, A; Serafini, G	2
Dercle, L; Girard, A; Rouanne, M; Vila Reyes, H	1
Abrahamsson, J; Almquist, H; Bläckberg, M; Brändstedt, J; Kollberg, P; Liedberg, F; Lyttkens, K; Simoulis, A; Sjödahl, G; Sörenby, A; Trägårdh, E	1
Bekers, EM; Donswijk, ML; Lahaye, MJ; Mertens, LS; Stokkel, LE; Stokkel, MPM; van Rhijn, BWG	1
Algün Gedik, A; Beyhan, E; Çermik, TF; Ergül, N; Erol, Ö	1
Chakra, MA; Dellis, A; Moussa, M; Papatsoris, A; Saad, W	1
Dong, A; Wang, Y; Zhao, Q	1
Li, D; Liu, S; Wang, Z; Wu, F; Yang, G	1
Almquist, H; Bläckberg, M; Cwikiel, M; Gudjonsson, S; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O	1
Horenblas, S; Mertens, LS	1
Bruining, A; Hendricksen, K; Horenblas, S; Mertens, LS; van de Putte, EEF; van der Heijden, MS; van Rhijn, BWG; Vegt, E	1
Aaltonen, K; Abrahamsson, J; Engilbertsson, H; Gudjonsson, S; Liedberg, F; Patschan, O; Rydén, L; Sjödahl, G	1
Bell, C; Bjerggaard Jensen, J; Bouchelouche, K; Høyer, S; Ipsen, P; Vind-Kezunovic, S	1
Kim, BS; Kim, Y; Lee, DH; Yoo, J; Yoon, HJ	1
Briganti, A; Castellucci, P; Colicchia, M; Evangelista, L; Fallanca, F; Fanti, S; Ficarra, V; Gallina, A; Incerti, E; Karnes, JR; Lowe, V; Moschini, M; Panareo, S; Picchio, M; Rambaldi, I; Schiavina, R; Zattoni, F	1
Lin, M; Lin, P; Naik, N	1
Ha, HK; Kim, SJ; Koo, PJ	1
Balaji, P; Froelich, J; Gencturk, M; Gupta, S; Jha, G; Konety, BR; Soubra, A	1
Eiber, M; Gschwend, JE; Horn, T; Maurer, T; Rauscher, I; Weber, WA	1
Cai, W; Ehlerding, EB; Lan, X	1
Girard, A; Rouanne, M	1
Dematons, M; Flaus, A; Granjon, D; Longo, MG; Prevot, N	1
Croteau, E; Levasseur, MA; Marcotte, ME; Panet, F; Pavic, M; Richard, MA	1
Liu, Y	1
Hu, JW; Li, Y; Qi, L; Yang, ZQ; Ye, H	1
Bongiovanni, M; Giovanella, L; Treglia, G	1
Fioole-Bruining, A; Horenblas, S; Mertens, LS; van Rhijn, BW; Vegt, E; Vogel, WV	1
Jiang, P; Lu, Y; Wang, N	1
Cook, G; Goh, V	1
d'Amico, A; Przeorek, C; Turska-d'Amico, M	1
Chen, YK; Cheng, RH; Hung, GU; Kao, CH; Su, CT; Tsui, CC; Yeh, CH	1
Dong, A; Lu, J; Wang, Y; Zhu, H; Zuo, C	1
Dasgupta, P; Evison, F; Goodfellow, H; Hughes, P; Hughes, S; Khan, MS; O'Brien, T; Rankin, S; Rottenberg, G; Viney, Z	1
Borbély, K; Géczi, L; Kásler, M	1
Bolton, D; Davies, I; Davis, ID; Fioole-Bruining, A; Horenblas, S; Lawrentschuk, N; Lee, ST; Manecksha, R; Mertens, LS; Mir, MC; Scott, AM; van Rhijn, BW; Vegt, E; Vogel, WV	1
Sagalowsky, AI	1
Lawrentschuk, N; Mertens, LS; Mir, MC; van Rhijn, BW	1
Bitencourt, AG; Guimarães, MD; Lima, EN; Marchiori, E	1
Chondrogiannis, S; Colletti, PM; Marzola, MC; Rubello, D	1
Eiber, M; Krause, BJ; Maurer, T	1
Han, Y; Li, H; Wang, Q; Wu, H	1
Fuccio, C; Ivaldi, GB; Mensi, M; Palumbo, R; Rubino, B; Scopesi, L; Spinapolice, EG; Trifirò, G	1
Alessi, A; Biasoni, D; Catanzaro, M; Crippa, F; Farè, E; Giannatempo, P; Gianni, AM; Maffezzini, M; Mariani, L; Miceli, R; Necchi, A; Nicolai, N; Padovano, B; Piva, L; Raggi, D; Salvioni, R; Serafini, G; Sonpavde, G; Stagni, S; Torelli, T	1
Aide, N; Coquan, E; Joly, F; Lasnon, C; Lefort, JM	1
Botto, H; Girma, A; Hervé, JM; Le Stanc, E; Lebret, T; Letang, N; Neuzillet, Y; Radulescu, C; Rouanne, M; Vilain, D; Yonneau, L	1
Cheng, CL; Chiu, KY; Ho, HC; Li, JR; Lin, WY; Lin, YC; Ou, YC; Su, CK; Tsai, SC	1
See, WA	1
Li, X; Liu, S; Wang, M; Yao, S	1
Almquist, H; Bläckberg, M; Cronberg, C; Garpered, S; Gudjonsson, S; Kleist, J; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O	1
Ahn, H; Hong, JH; Hong, S; Jeong, IG; Kim, CS; You, D	1
Öztürk, H	2
Balar, AV; Friedman, KP; Huang, WC; Jackson, K; Rosenkrantz, AB	1
Ayten, O; Dogan, D; Ozkisa, T; Yavas, I; Yigit, N; Zor, M	1
Chen, C; Kang, Q; Lu, J; Wang, L; Xing, W; Zhang, H	1
Fujii, Y; Fukui, I; Kihara, K; Kohno, A; Koizumi, M; Komai, Y; Masuda, H; Sakai, Y; Tanaka, H; Urakami, S; Yamamoto, S; Yonese, J; Yoshida, S; Yuasa, T	1
Hess, S; Høilund-Carlsen, PF; Lund, L; Petersen, H; Poulsen, MH	1
Bouchelouche, K; Choyke, PL	1
Cui, XJ; Fang, N; Wang, YL; Wu, ZJ; Zeng, L	1
Alhammadi, A; Lebret, T; Radulescu, C; Rouanne, M; Vilain, D	1
Chang, SS	2
Agarwal, KK; Kumar, R; Roy, SG	1
Dahm, P; Froehlich, J; Goldfarb, R; Hayward, D; Jha, G; Konety, BR; Soubra, A	1
Albano, D; Alongi, P; Baldari, S; Caobelli, F; Gentile, R; Gilardi, MC; Midiri, M; Russo, G; Stefano, A	1
Cai, L; Chen, Y; Shao, F; Wang, X; Zou, Y	1
Balar, AV; Friedman, KP; Huang, WC; Jackson, K; Ponzo, F; Raad, RA; Rosenkrantz, AB	1
Lucignani, G; Russo, G; Tagliabue, L	1
Das, C; Parida, GK; Roy, SG; Shamim, SA; Singhal, A; Tripathy, S	1
Obando, JA; Samii, JM; Yasrebi, M	1
Billiet, I; Lesage, K; Maes, A; Pottel, H; Swinnen, G; Vanneste, A; Werbrouck, P	1
Sherif, A	1
Cao, D; Dehdashti, F; Gao, F; Grubb, RL; Humphrey, PA; Katz, MD; Kibel, AS; Klim, AP; Siegel, BA; Siegel, C	1
Gundogdu, S; Ilgan, S; Koca, G	1
Hakenberg, OW; Protzel, C	1
Chuang, KW; Coakley, FV; Hawkins, RA; Konety, BR; Patil, VV; Sollitto, RA; Wang, ZJ	1
Demeter, SJ; Ducharme, J; Leslie, WD; Nijjar, S; Patterson, J	1
Dua, S; Gupta, K; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR	1
Cui, R; Li, F; Zhuang, H	1
Fradet, Y; Friede, J; Lacombe, L; Lodde, M; Morin, F; Saourine, A	1
Chao, TB; Chen, CJ; Shih, DF	1
Avril, N; Dambha, F; Murray, I; Powles, T; Sahdev, A; Shamash, J	1
Hsieh, TC; Juang, GD; Kao, CH; Liang, JA; Shen, YY; Yeh, LH	1
Akin, O; Apolo, AB; Bajorin, DF; Milowsky, MI; Riches, J; Schöder, H; Trout, A	1
Bouchelouche, K; Gerke, O; Holt, P; Jensen, TK; Marcussen, N; Riehmann, M; Svolgaard, B	1
Aschoff, P; Pfannenberg, C; Reimold, M; Werner, MK	1
Abdelmalik, AG; Altinyay, ME; Brickman, TM; Nguyen, NC; Osman, MM; Varvares, MA	1
Baniel, J; Golan, S; Groshar, D; Sopov, V	1
Blais, N	1
Ciarallo, A; Lisbona, R; Makis, W	1
Chen, JH; Kao, CH; Liang, JA; Lin, CC; Lin, WY; Lu, YY; Wang, HY	1
Belakhlef, S; Church, C; Jani, C; Lakhanpal, S	1
Cheng, J; Hu, S; Pan, L; Xu, J; Yang, Z; Ye, D; Zhang, Y	1
Mirtcheva, R; Wosnitzer, B	1
Percarpio, R; Seltzer, M; Siegel, A	1
Bertagna, F; Fisogni, S; Giubbini, R; Lena, MS; Lucchini, S; Motta, F	1
Aggarwal, MM; Bhattacharya, A; Kashyap, R; Mandal, AK; Manohar, K; Mittal, BR	1
Adewole, AD; Kim, AW; Kraev, AI; Roman, SA	1
Cheng, J; Hu, S; Pan, L; Wang, M; Xu, J; Yang, Z; Ye, D; Zhang, J; Zhang, Y	1
Bruin, NM; de Blok, WM; Fioole-Bruining, A; Horenblas, S; Mertens, LS; van Rhijn, BW; Vegt, E; Vogel, WV	1
Aliyev, A; Ergül, N; Halac, M; Kaya, R; Ozhan, M; Sağer, S; Yılmaz, S	1
Bergman, AM; Fioole-Bruining, A; Horenblas, S; Kerst, JM; Mertens, LS; van Rhijn, BW; Vegt, E; Vogel, WV	1
Abramson, S; Arora, VC; Fleming, S; LaQuaglia, MP; Magnan, H; Price, AP; Sohn, MJ	1
Dogra, PN; Kumar, R; Naswa, N; Nayak, B	1
Ansquer, C; Bodere, F; Bouchot, O; Branchereau, J; Hitier-Berthault, M; Renaudin, K; Rigaud, J	1
Hickeson, M; Lisbona, R; Makis, W; Nahal, A; Rakheja, R	1
Alavi, A; Chacko, TK; Hickeson, M; Zhuang, H	1
Bourguet, P	1
Liu, IJ; Nino-Murcia, M; Segall, GM; Terris, MK	1
Akeboshi, M; Hataji, O; Nakatsuka, A; Taguchi, O; Takao, M; Takeda, K; Yamakado, K	1
Barbeaux, A; Borght, TV; Krug, B; Lacrosse, M; Luyx, D; Pirson, AS	1
Larson, SM; Schöder, H	1
Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S	1
Bonardel, G; Foehrenbach, H; Gontier, E; Mantzarides, M; Papathanassiou, D; Soret, M	1
Hung, GU; Lin, WY; Tsai, SC	1
Drieskens, O; Flamen, P; Mortelmans, L; Oyen, R; Van Poppel, H; Vankan, Y	1
Espiritu, JI; Lai, YH; Liu, IJ; Nino-Murcia, M; Segall, GM; Srinivas, S; Terris, MK	1
Gamie, S; Iagaru, A; Segall, G	1
Castaldo, S; Delaloye, AB; Delaloye, JF; Jichlinski, P; Kamel, EM; Leisinger, HJ; Malterre, J; Meuwly, JY; Prior, JO; Vaucher, L	1
Albertotti, C; Anjos, DA; Camargo, EE; Etchebehere, EC; Ramos, CD; Santos, AO	1
Bourguet, P; Montravers, F; Planchamp, F; Vincendeau, S	1
Boddington, SE; Coakley, FV; Franc, BL; Hawkins, RA; Purcell, DD; Yeh, BM	1
Fulham, MJ; Mohamed, A; Thambugala, GM	1
Inoue, M; Ito, M; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Numao, N	1
Bouchelouche, K; Oehr, P	2
Conti, PS; Henderson, RW; Jadvar, H; Quan, V	1
Bachor, R; Gropengiesser, F; Hautmann, RE; Kocher, F; Reske, SN	1
Ahlström, H; Andersson, J; Långström, B; Letocha, H; Malmström, PU; Nilsson, S	1
Greenough, R; Grossman, HB; Kison, PV; Kosuda, S; Wahl, RL	1
Fisher, S; Grossman, HB; Kison, PV; Kosuda, S; Wahl, RL	1
Abdel-Dayem, HM; Abujudeh, H; Atay, S; El-Zeftawy, HM; Luo, JQ; Marans, HY; Mithilesh, K; Naddaf, SY; Omar, WS; Radin, AI; Wong, S	1
Bachor, R; Hautmann, R; Kotzerke, J; Reske, SN	1
Avril, N; Breul, J; Hartung, R; Hofer, C; Kübler, H	1
Grossman, HB; Harney, JV; Hutchins, GD; Kuhl, DE; Liebert, M; Wahl, RL; Wedemeyer, G	1

Reviews

27 review(s) available for fluorodeoxyglucose f18 and Bladder Cancer

Article	Year
PET/CT in Bladder Cancer: An Update. Seminars in nuclear medicine, 2022, Volume: 52, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms	2022
The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer. Urologic oncology, 2022, Volume: 40, Issue:10 Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2022
Predictive Value of 18 F-FDG PET/CT for Assessment of Tumor Response to Neoadjuvant Chemotherapy in Bladder Cancer. Clinical nuclear medicine, 2023, Jul-01, Volume: 48, Issue:7 Topics: Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms	2023
Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis. Urology journal, 2020, 04-20, Volume: 17, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms	2020
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer. Current opinion in urology, 2020, Volume: 30, Issue:5 Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Muscles; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis. Oncology, 2018, Volume: 95, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; ROC Curve; Sensitivity and Specificity; Urinary Bladder Neoplasms	2018
Positron-emission tomography imaging in urological oncology: Current aspects and developments. International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:11 Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Medical Oncology; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms	2018
Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for detecting bladder lesions? A meta-analysis of the literature. Urologia internationalis, 2014, Volume: 92, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Positron-Emission Tomography; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
[Why is PET/CT essential in urooncology?]. Magyar onkologia, 2013, Volume: 57, Issue:4 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms; Urogenital Neoplasms	2013
[Molecular multimodal hybrid imaging in prostate and bladder cancer]. Der Urologe. Ausg. A, 2014, Volume: 53, Issue:4 Topics: Biomarkers, Tumor; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Molecular Imaging; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Penile metastases from bladder and prostate cancer detected by PET/CT: a report of 3 cases and a review of literature. Clinical genitourinary cancer, 2014, Volume: 12, Issue:4 Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Penile Neoplasms; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2015
FDG in Urologic Malignancies. PET clinics, 2014, Volume: 9, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urologic Neoplasms	2014
PET/Computed Tomography in Renal, Bladder, and Testicular Cancer. PET clinics, 2015, Volume: 10, Issue:3 Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2015
Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies. PET clinics, 2016, Volume: 11, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	2016
The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World journal of urology, 2016, Volume: 34, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Urinary Bladder Neoplasms	2016
Emerging apoptosis agonists for bladder cancer. Expert opinion on emerging drugs, 2009, Volume: 14, Issue:4 Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms	2009
18F-FDG PET/CT of transitional cell carcinoma. AJR. American journal of roentgenology, 2009, Volume: 193, Issue:6 Topics: Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2009
The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers. International journal of urology : official journal of the Japanese Urological Association, 2010, Volume: 17, Issue:6 Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urologic Neoplasms	2010
Are we undertreating invasive bladder cancer? Optimizing outcomes in a high-risk disease. Current opinion in supportive and palliative care, 2011, Volume: 5, Issue:3 Topics: Antineoplastic Agents; Biomarkers, Tumor; Cystectomy; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Factors; Treatment Outcome; Urinary Bladder Neoplasms	2011
Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis. European journal of radiology, 2012, Volume: 81, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2012
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers]. Bulletin du cancer, 2003, Volume: 90 Spec No Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urologic Neoplasms	2003
Positron emission tomography for prostate, bladder, and renal cancer. Seminars in nuclear medicine, 2004, Volume: 34, Issue:4 Topics: Carcinoma, Renal Cell; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Treatment Outcome; Urinary Bladder Neoplasms	2004
Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. The Journal of urology, 2008, Volume: 179, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2008
Recent developments in urologic oncology: positron emission tomography molecular imaging. Current opinion in oncology, 2008, Volume: 20, Issue:3 Topics: Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm, Residual; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms	2008
Diagnosis and monitoring of urological tumors using positron emission tomography. European urology, 2001, Volume: 40, Issue:5 Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms	2001

Trials

14 trial(s) available for fluorodeoxyglucose f18 and Bladder Cancer

Article	Year
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial. BMC cancer, 2021, Oct-18, Volume: 21, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Prospective Studies; Quality of Life; Radiopharmaceuticals; Risk Assessment; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2021
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial. BMC cancer, 2021, Oct-29, Volume: 21, Issue:1 Topics: Algorithms; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm, Residual; Organ Sparing Treatments; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms	2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Enhanced Application of 18F-FDG PET/CT in Bladder Cancer by Adding Early Dynamic Acquisition to a Standard Delayed PET Protocol. Clinical nuclear medicine, 2017, Volume: 42, Issue:10 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Urinary Bladder Neoplasms	2017
The effect of furosemide dose timing on bladder activity in oncology imaging with 18F-fluorodeoxyglucose PET/CT. Nuclear medicine communications, 2010, Volume: 31, Issue:2 Topics: Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Image Interpretation, Computer-Assisted; Liver; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms	2010
Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study. Nuclear medicine communications, 2012, Volume: 33, Issue:11 Topics: Aged; Catheters; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2012
Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Diuresis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult	2013
18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. International journal of urology : official journal of the Japanese Urological Association, 2013, Volume: 20, Issue:8 Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cystectomy; Fluorodeoxyglucose F18; Lymph Node Excision; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2013
Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of transitional cell carcinoma. Advances in experimental medicine and biology, 2003, Volume: 539, Issue:Pt A Topics: Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Diuretics; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Urinary Bladder Neoplasms	2003
Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. Journal of vascular and interventional radiology : JVIR, 2004, Volume: 15, Issue:5 Topics: Aged; Carcinoma; Catheter Ablation; Contrast Media; Digestive System Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluoroscopy; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Iohexol; Leiomyosarcoma; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms	2004
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. The Annals of thoracic surgery, 2005, Volume: 79, Issue:1 Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms	2005
FDG-PET for preoperative staging of bladder cancer. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Belgium; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Urinary Bladder Neoplasms; Whole Body Imaging	2005
Evaluation of fluorodeoxyglucose positron emission tomography imaging in metastatic transitional cell carcinoma with and without prior chemotherapy. Urologia internationalis, 2006, Volume: 77, Issue:1 Topics: Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms	2006
18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:5 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms	2007

Other Studies

123 other study(ies) available for fluorodeoxyglucose f18 and Bladder Cancer

Article	Year
Utility of FDG-PET CT scan to detect an incidental rare recurrence of carcinoma urinary bladder following radical cystectomy. BMJ case reports, 2021, Oct-27, Volume: 14, Issue:10 Topics: Carcinoma; Cystectomy; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Urinary Bladder; Urinary Bladder Neoplasms	2021
Impact of Clinical genitourinary cancer, 2022, Volume: 20, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Muscles; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Urinary Bladder Neoplasms	2022
Rare osteoarticular complications on [18F]FDG-PET/CT - following intravesical BCG immunotherapy for bladder cancer. Nuclear medicine review. Central & Eastern Europe, 2022, Volume: 25, Issue:1 Topics: BCG Vaccine; Fluorodeoxyglucose F18; Humans; Immunotherapy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Urinary Bladder Neoplasms	2022
Prostate-Specific Membrane Antigen-Avid Bone Metastases From Urothelial Carcinoma of the Bladder. Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10 Topics: Bone Neoplasms; Carcinoma, Transitional Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms	2022
18 F-FDG PET/CT in Urethral Metastases From Bladder Cancer. Clinical nuclear medicine, 2022, 11-01, Volume: 47, Issue:11 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Urinary Bladder Neoplasms	2022
Association between Serum Carcino-embryonic Antigen Levels and Micropapillary Bladder Cancer Metastasis in an Elderly Male. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022, Volume: 32, Issue:8 Topics: Adenocarcinoma, Papillary; Aged; BCG Vaccine; Carcinoembryonic Antigen; Carcinoma, Papillary; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Urinary Bladder; Urinary Bladder Neoplasms	2022
Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy. Urologia internationalis, 2023, Volume: 107, Issue:3 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymphatic Metastasis; Male; Middle Aged; Muscles; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms	2023
Bilateral Adrenal and testicular Tumours; When a Simple Diagnosis Becomes Complicated. Urology, 2023, Volume: 175 Topics: Aged; BCG Vaccine; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Testicular Neoplasms; Urinary Bladder Neoplasms	2023
Added Clinical Value of Clinical genitourinary cancer, 2023, Volume: 21, Issue:3 Topics: Aged; Cystectomy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Non-Muscle Invasive Bladder Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Urinary Bladder Neoplasms	2023
Incidental Detection of Second Primary in Bladder on PET scan of a Patient with Colon Adenocarcinoma. JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:11 Topics: Adenocarcinoma; Carcinoma, Transitional Cell; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms	2022
[THE USEFULNESS OF POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF METASTASIS IN PATIENTS WITH UROTHELIAL CARCINOMA]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2022, Volume: 113, Issue:2 Topics: Aged; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2022
18 F-FDG PET-Positive Large Pelvic Granuloma Mimicking Malignant Bladder Tumor. Clinical nuclear medicine, 2023, Jun-01, Volume: 48, Issue:6 Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Granuloma; Humans; Male; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2023
Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study. BJU international, 2023, Volume: 132, Issue:4 Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Muscles; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2023
Solitary Axillary Lymph Node Metastasis From Bladder Cancer Detected by FDG PET/CT. Clinical nuclear medicine, 2023, 11-01, Volume: 48, Issue:11 Topics: Aged; Axilla; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms	2023
Re: Delayed The Journal of urology, 2020, Volume: 203, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Urinary Bladder Neoplasms	2020
Pilot Study of [ Clinical genitourinary cancer, 2020, Volume: 18, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Muscles; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms	2020
A rare presentation of primary synchronous renal tract tumours on (18F)- fluorodeoxyglucose positron emission tomography- computed tomography. JPMA. The Journal of the Pakistan Medical Association, 2020, Volume: 70, Issue:5 Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2020
Disseminated Bacillus Calmette-Guérin Infection Detected on FDG PET/CT Following Intravesical Bacillus Calmette-Guérin Therapy. Clinical nuclear medicine, 2020, Volume: 45, Issue:7 Topics: Administration, Intravesical; BCG Vaccine; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Immunotherapy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tuberculosis; Urinary Bladder Neoplasms	2020
Relevance of concurrent hypercalcemia in ureteric sarcoidosis complicated with bladder urothelial carcinoma: a case report. BMC nephrology, 2020, 06-22, Volume: 21, Issue:1 Topics: Carcinoma, Transitional Cell; Cystoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hydronephrosis; Hypercalcemia; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Renal Insufficiency; Sarcoidosis; Tomography, X-Ray Computed; Ureteral Diseases; Ureteral Neoplasms; Ureteroscopy; Urinary Bladder Neoplasms	2020
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab. Urologic oncology, 2021, Volume: 39, Issue:4 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Urinary Bladder Neoplasms	2021
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy. European urology focus, 2021, Volume: 7, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Cystectomy; Fluorodeoxyglucose F18; Humans; Incidence; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Urinary Bladder Neoplasms	2021
"Future role of [18F]-FDG PET/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy?" Urologic oncology, 2021, Volume: 39, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Fluorodeoxyglucose F18; Glucose; Humans; Immunotherapy; Lymph Nodes; Muscles; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Urinary Bladder Neoplasms	2021
Complete metabolic response with [ BJU international, 2022, Volume: 129, Issue:2 Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Urinary Bladder Neoplasms	2022
The Diagnostic Value of FDG-PET/CT for Urachal Cancer. Clinical genitourinary cancer, 2021, Volume: 19, Issue:5 Topics: Carcinoma, Transitional Cell; Electrons; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2021
Synchronous Bilateral Adrenal Gland Metastases of Bladder Carcinoma Revealed on 18F-FDG PET/CT. Clinical nuclear medicine, 2021, Sep-01, Volume: 46, Issue:9 Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged, 80 and over; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Urinary Bladder; Urinary Bladder Neoplasms	2021
The role of 18F-FDG PET/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer. Urologic oncology, 2021, Volume: 39, Issue:12 Topics: Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Urinary Bladder Neoplasms	2021
FDG PET/CT in a Case of Lynch Syndrome With Synchronous Inverted Urothelial Papilloma of the Bladder, Urothelial Carcinoma of the Ureter, and Jejunal Adenocarcinoma. Clinical nuclear medicine, 2022, Jan-01, Volume: 47, Issue:1 Topics: Adenocarcinoma; Carcinoma, Transitional Cell; Colorectal Neoplasms, Hereditary Nonpolyposis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Papilloma; Positron Emission Tomography Computed Tomography; Ureter; Ureteral Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms	2022
A Rare Case of Urachal Carcinoma Metastatic to Thoracic Vertebra Detected by FDG PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:7 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Spinal Neoplasms; Thoracic Vertebrae; Urinary Bladder Neoplasms	2017
[ Scandinavian journal of urology, 2017, Volume: 51, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine	2017
Related to: [ Scandinavian journal of urology, 2017, Volume: 51, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2017
FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy. International urology and nephrology, 2017, Volume: 49, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Urinary Bladder Neoplasms	2017
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival. Urologic oncology, 2017, Volume: 35, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Survival Analysis; Urinary Bladder Neoplasms	2017
Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and European urology focus, 2019, Volume: 5, Issue:1 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, High-Volume; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period; Reference Standards; Sensitivity and Specificity; Treatment Outcome; Urinary Bladder Neoplasms	2019
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study. Abdominal radiology (New York), 2018, Volume: 43, Issue:9 Topics: Aged; Carcinoma, Transitional Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Italy; Magnetic Resonance Imaging; Male; Minnesota; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2018
Genitourinary involvement of lymphomas on FDG-PET. The British journal of radiology, 2018, Volume: 91, Issue:1086 Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms	2018
FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients. Clinical genitourinary cancer, 2018, Volume: 16, Issue:5 Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Treatment Outcome; Urinary Bladder Neoplasms	2018
Predicting PD-1/PD-L1 status in bladder cancer with European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:4 Topics: B7-H1 Antigen; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Programmed Cell Death 1 Receptor; Urinary Bladder Neoplasms	2019
Comment on: Relationship between the expression of PD-1/PD-L1 and European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:6 Topics: B7-H1 Antigen; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Programmed Cell Death 1 Receptor; Urinary Bladder Neoplasms	2019
18F-FDG PET/CT in Urachal Abscess. Clinical nuclear medicine, 2019, Volume: 44, Issue:5 Topics: Abscess; Carcinoma; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms; Urinary Tract Infections	2019
Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:11 Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Breast; Breast Implants; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Rupture; Urinary Bladder Neoplasms; Urothelium	2019
FDG PET/CT and renal scan demonstrations of carcinoma in the urinary bladder and bladder diverticulum. Clinical nuclear medicine, 2013, Volume: 38, Issue:7 Topics: Diverticulum; Fluorodeoxyglucose F18; Humans; Kidney; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Mertiatide; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms	2013
Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2013, Volume: 33, Issue:2 Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2013
A rare case of small cell neuroendocrine carcinoma of the urinary bladder incidentally detected by F-18-FDG PET/CT. Endocrine, 2014, Volume: 45, Issue:1 Topics: Aged; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Tomography, Emission-Computed; Urinary Bladder Neoplasms	2014
Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. BJU international, 2013, Volume: 112, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2013
Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer. BJU international, 2013, Volume: 112, Issue:6 Topics: Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2013
Repetition of FDG PET study in the same day after appropriate patient preparation revealed two new cancer localizations: a case report. Nuclear medicine review. Central & Eastern Europe, 2013, Volume: 16, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Time Factors; Urinary Bladder Neoplasms	2013
A new method for detecting urinary bladder cancer by using FDG PET/CT. Technology in cancer research & treatment, 2014, Volume: 13, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Urinary Bladder Neoplasms	2014
Organized urachal abscess mimicking urachal carcinoma on FDG PET/CT. Clinical nuclear medicine, 2014, Volume: 39, Issue:1 Topics: Abscess; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU international, 2014, Volume: 114, Issue:3 Topics: Abdomen; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cystectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer. Urology, 2014, Volume: 83, Issue:2 Topics: Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Editorial comment. Urology, 2014, Volume: 83, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Reply: To PMID 24468513. Urology, 2014, Volume: 83, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
18FDG PET/CT findings in the unusual urachal adenocarcinoma. Clinical nuclear medicine, 2014, Volume: 39, Issue:9 Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT. Clinical nuclear medicine, 2015, Volume: 40, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2015
[Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2014, Volume: 34, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma. Clinical genitourinary cancer, 2014, Volume: 12, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Disease-Free Survival; Doxorubicin; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine	2014
Diuretic ¹⁸F-FDG PET/CT for therapy monitoring in urothelial bladder cancer. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:9 Topics: Diuretics; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium	2014
Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol. Nuklearmedizin. Nuclear medicine, 2015, Volume: 54, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Patient Satisfaction; Patient-Centered Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms; Urination	2015
Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas Urologic oncology, 2014, Volume: 32, Issue:8 Topics: Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT. Clinical nuclear medicine, 2015, Volume: 40, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2015
[(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy. Scandinavian journal of urology, 2015, Volume: 49, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cohort Studies; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle, Smooth; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2015
FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Annals of surgical oncology, 2015, Volume: 22, Issue:9 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2015
Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography. Cancer research and treatment, 2015, Volume: 47, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms; Young Adult	2015
Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer. Clinical nuclear medicine, 2015, Volume: 40, Issue:8 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms	2015
Mediastinal granulomatous lymphadenitis after intravesical bacillus Calmette-Guerin treatment mimicking distant metastasis of primary bladder carcinoma. Archivos de bronconeumologia, 2015, Volume: 51, Issue:10 Topics: Administration, Intravesical; Adult; Antitubercular Agents; BCG Vaccine; Carcinoma, Transitional Cell; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphadenitis; Male; Mediastinal Diseases; Mediastinal Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculoma; Tuberculosis, Lymph Node; Urinary Bladder Neoplasms	2015
Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urologia internationalis, 2016, Volume: 96, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires; Urinary Bladder Neoplasms; Urothelium	2016
Comparing RECIST with EORTC criteria in metastatic bladder cancer. Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2016
18F-FDG PET/CT Findings of Metastasis to Spongy Body of Penis From Urothelial Carcinoma of Bladder. Clinical nuclear medicine, 2016, Volume: 41, Issue:5 Topics: Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2016
Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer. World journal of surgical oncology, 2015, Sep-17, Volume: 13 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Muscle Neoplasms; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Penile Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Urinary Bladder Neoplasms	2015
Re: Potential Impact of 18F-FDG PET/CT on Patients Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. The Journal of urology, 2015, Volume: 194, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2015
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:2 Topics: Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Urinary Bladder Neoplasms	2017
Unexpected Detection of Urinary Bladder Cancer on Dual Phase 18F-NaF PET/CT in a Patient With Back Pain. Clinical nuclear medicine, 2016, Volume: 41, Issue:11 Topics: Aged; Back Pain; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride; Urinary Bladder Neoplasms	2016
Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI. Clinical nuclear medicine, 2017, Volume: 42, Issue:1 Topics: Aged; Carcinoma, Transitional Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvis; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms	2017
18F-FDG PET/CT in Bladder Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:12 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms	2016
Re: PET/Computed Tomography in Renal, Bladder, and Testicular Cancer. The Journal of urology, 2017, Volume: 197, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms	2017
Incidentally Detected Penile Metastases in a Patient of Carcinoma Urinary Bladder on Follow-up FDG PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:5 Topics: Aftercare; Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Penile Neoplasms; Penis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms	2017
A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography. Clinical nuclear medicine, 2008, Volume: 33, Issue:11 Topics: Adenocarcinoma; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urinary Bladder Neoplasms; Whole Body Imaging	2008
FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. European urology, 2010, Volume: 57, Issue:4 Topics: Aged; Aged, 80 and over; Belgium; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms	2010
Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. European urology, 2010, Volume: 57, Issue:4 Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2010
Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-10, Volume: 27, Issue:26 Topics: Adult; Aged; Aged, 80 and over; Cystectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Male; Middle Aged; Muscles; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms	2009
Incidental detection of granulomatous prostatitis by F-18 FDG PET/CT in a patient with bladder cancer: a rare complication of BCG instillation therapy. Clinical nuclear medicine, 2009, Volume: 34, Issue:9 Topics: BCG Vaccine; Fluorodeoxyglucose F18; Granuloma; Humans; Incidental Findings; Instillation, Drug; Male; Middle Aged; Positron-Emission Tomography; Prostatitis; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2009
Interesting image. Correlative imaging with FDG PET-CT and MRI of an unusual recurrence of urothelial cancer in an ileal conduit. Clinical nuclear medicine, 2010, Volume: 35, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urinary Diversion; Urothelium	2010
Interesting image. Two primary colon cancers shown on FDG PET/CT performed to evaluate possible lung metastases from bladder cancer. Clinical nuclear medicine, 2010, Volume: 35, Issue:1 Topics: Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2010
Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU international, 2010, Volume: 106, Issue:5 Topics: Aged; Aged, 80 and over; Cystectomy; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms	2010
Recurrent colon cancer involving the urinary bladder identified with F-18 FDG PET/CT after forced diuresis. Clinical nuclear medicine, 2010, Volume: 35, Issue:4 Topics: Aged; Colonic Neoplasms; Diuretics; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2010
Feasible method to successfully uncover a urothelial carcinoma in the urinary bladder on the FDG PET/CT scan masked by physiological urine radioactivity. Clinical nuclear medicine, 2010, Volume: 35, Issue:6 Topics: Aged; Artifacts; Carcinoma, Papillary; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radioactivity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2010
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Sep-01, Volume: 28, Issue:25 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, Emission-Computed; Urinary Bladder Neoplasms	2010
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scandinavian journal of urology and nephrology, 2011, Volume: 45, Issue:2 Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urothelium	2011
FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies. The British journal of radiology, 2011, Volume: 84, Issue:999 Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Spinal Neoplasms; Spine; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2011
FDG PET/CT incidental diagnosis of a synchronous bladder cancer as a fourth malignancy in a patient with head and neck cancer. Clinical nuclear medicine, 2011, Volume: 36, Issue:6 Topics: Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2011
Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study. The Journal of urology, 2011, Volume: 186, Issue:2 Topics: Abdominal Neoplasms; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Transitional Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2011
Three synchronous primary malignancies detected by F-18 FDG PET/CT: breast, rectal, and urothelial bladder carcinomas. Clinical nuclear medicine, 2011, Volume: 36, Issue:9 Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urothelium; Whole Body Imaging	2011
Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: a novel approach. Clinical nuclear medicine, 2012, Volume: 37, Issue:4 Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Humans; Linear Models; Male; Multimodal Imaging; Perfusion Imaging; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2012
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer. International journal of urology : official journal of the Japanese Urological Association, 2012, Volume: 19, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2012
Extraperitoneal urinary bladder perforation detected by FDG PET/CT. Journal of radiology case reports, 2011, Volume: 5, Issue:4 Topics: Adenocarcinoma; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium	2011
Colon cancer metastatic to a urachus diagnosed by PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:5 Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2012
Absence of urine production due to renal failure enables clear visualization of primary urinary bladder carcinoma on 18F-FDG PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:6 Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Renal Insufficiency; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urine	2012
A rare case of malignant urinary bladder paraganglioma with distant metastases demonstrated by 18F-FDG PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2012
A fluorodeoxyglucose avid mediastinal parathyroid adenoma masquerading as metastatic bladder cancer. Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:3 Topics: Carcinoma, Transitional Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Middle Aged; Parathyroid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms	2012
Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? Annals of nuclear medicine, 2012, Volume: 26, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms; Whole Body Imaging	2012
Delayed imaging of the pelvis with diluted and filled bladder: a simple and efficient method in FDG PET/CT imaging of bladder carcinoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms	2012
FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer. The Journal of urology, 2013, Volume: 189, Issue:5 Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2013
Characteristic imaging features of desmoplastic small round cell tumour. Pediatric radiology, 2013, Volume: 43, Issue:1 Topics: Adolescent; Adult; Bone Neoplasms; Child; Desmoplastic Small Round Cell Tumor; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult	2013
Urinary bladder leiomyosarcoma: staging with 18F-FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:5 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2013
How high can the standardized uptake value be? Clinical nuclear medicine, 2002, Volume: 27, Issue:11 Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Thyroid Neoplasms; Tissue Distribution; Urinary Bladder Neoplasms	2002
Bladder hernia simulating metastatic lesion on FDG PET study. Clinical nuclear medicine, 2004, Volume: 29, Issue:11 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Hernia; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Urinary Bladder Diseases; Urinary Bladder Neoplasms	2004
High-grade lymphoma of the bladder visualized on PET. Clinical nuclear medicine, 2005, Volume: 30, Issue:7 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Severity of Illness Index; Urinary Bladder Neoplasms	2005
A pitfall of FDG-PET image interpretation: accumulation of FDG in the dependent area of the urinary bladder after bladder irrigation--the usefulness of the prone position. Clinical nuclear medicine, 2005, Volume: 30, Issue:9 Topics: Adult; Artifacts; Diagnostic Errors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Therapeutic Irrigation; Urinary Bladder; Urinary Bladder Neoplasms	2005
F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases. Clinical nuclear medicine, 2006, Volume: 31, Issue:8 Topics: Aged; Bone Neoplasms; Carcinoma, Small Cell; Chromogranins; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Prostate-Specific Antigen; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Neoplasms	2006
Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:11 Topics: Adult; Diuresis; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Neoplasm Staging; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2006
[2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2007, Volume: 17, Issue:2 Topics: Fluorodeoxyglucose F18; France; Humans; Image Processing, Computer-Assisted; Kidney Neoplasms; Male; Medical Laboratory Science; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms	2007
Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause. AJR. American journal of roentgenology, 2007, Volume: 189, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Iohexol; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Urinary Bladder; Urinary Bladder Neoplasms	2007
Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma. Australasian radiology, 2007, Volume: 51 Spec No. Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2007
[Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report]. Hinyokika kiyo. Acta urologica Japonica, 2007, Volume: 53, Issue:9 Topics: Carcinoma; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2007
[F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. International journal of clinical oncology, 2008, Volume: 13, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2008
[Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results]. Der Urologe. Ausg. A, 1995, Volume: 34, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Renal Cell; Combined Modality Therapy; Deoxyglucose; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postoperative Complications; Salvage Therapy; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms	1995
Positron emission tomography in the diagnosis and staging of urinary bladder cancer. Acta radiologica (Stockholm, Sweden : 1987), 1996, Volume: 37, Issue:2 Topics: Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	1996
Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. European journal of nuclear medicine, 1997, Volume: 24, Issue:6 Topics: Carcinoma, Transitional Cell; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Tomography, Emission-Computed; Urinary Bladder Neoplasms	1997
Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Annals of nuclear medicine, 1997, Volume: 11, Issue:3 Topics: Adult; Aged; Animals; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Retrospective Studies; Testis; Tomography, Emission-Computed; Urinary Bladder; Urinary Bladder Neoplasms	1997
Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:4 Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Neoplasms	1998
[Lymph node staging of bladder neck carcinoma with positron emission tomography]. Der Urologe. Ausg. A, 1999, Volume: 38, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Urinary Bladder Neoplasms	1999
Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. The Journal of urology, 1991, Volume: 145, Issue:2 Topics: Animals; Carcinoma, Transitional Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Transplantation; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder Neoplasms	1991